We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current L1CA34 market cap is 21.72B. The company's latest EPS is USD 4.9234 and P/E is 40.90.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.61B | 3.67B | 3.78B | 2.29B | 3.06B |
| Operating Income | 471.1M | 88.4M | 338.9M | 256M | 252M |
| Net Income | 352.8M | 76.1M | 212.9M | 188.9M | 183.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.55B | 13.98B | 16.12B | 14.88B | 12.16B |
| Operating Income | 1.34B | 2.45B | 3.29B | 1.78B | 724.2M |
| Net Income | 823.8M | 1.56B | 2.38B | 1.28B | 418M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.83B | 20.16B | 20.2B | 17.72B | 16.89B |
| Total Liabilities | 9.71B | 10.04B | 9.84B | 8.91B | 8.99B |
| Total Equity | 10.09B | 10.1B | 10.34B | 8.79B | 7.87B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.05B | 20.07B | 20.39B | 20.16B | 16.73B |
| Total Liabilities | 10.46B | 10.69B | 10.09B | 10.04B | 8.83B |
| Total Equity | 7.57B | 9.36B | 10.27B | 10.1B | 7.88B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.3B | 1.96B | 121.2M | 472.6M | 748.1M |
| Investing | -1.38B | -1.65B | -99.7M | -353.3M | -840.9M |
| Financing | -949.6M | -1.32B | -60.6M | 1.48B | 387.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.44B | 2.14B | 3.11B | 1.96B | 1.33B |
| Investing | -1.28B | -643.2M | -884.6M | -1.65B | -1.17B |
| Financing | -252.7M | -517.4M | -2.07B | -1.32B | -59.3M |
| Market Cap | 21.72B |
| Price to Earnings Ratio | 40.90 |
| Price to Sales Ratio | 1.41 |
| Price to Cash Ratio | 31.85 |
| Price to Book Ratio | 2.17 |
| Dividend Yield | - |
| Shares Outstanding | 84.9M |
| Average Volume (1 week) | 5 |
| Average Volume (1 Month) | 4 |
| 52 Week Change | -10.42% |
| 52 Week High | 291.01 |
| 52 Week Low | 244.57 |
| Spread (Intraday) | 1.04 (0.41%) |
| Company Name | Laboratory Corp of America Holdings |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.labcorp.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
